News
After the FDA rejection of Zurzuvae in one type of depression, and the triple failure of neuro asset dalzanemdor, Sage was ...
The top companies supporting the development of a hydrogen economy for decarbonisation include Linde, Air Liquide, Air ...
DelveInsight's Frontotemporal Dementia Market Insights report includes a comprehensive understanding of current treatment ...
Logo TV, the first 24-hour LGBTQIA+ television network, launched June 30, 2005. Logo's first president reflects on its ...
For Capstan, AbbVie will pay up to $2.1 billion in cash, subject to certain customary adjustments. Capstan is backed by ...
Biogen Inc. closed 46.93% short of its 52-week high of $238.00, which the company achieved on July 12th.
Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.
Shares of Biogen Inc. BIIB slipped 1.79% to $124.76 Monday, on what proved to be an all-around positive trading session for ...
“I’m delighted to welcome Anne Marie Cook to Phathom. Her experience and broad skills will be highly impactful as we work to build Phathom into a leading GI company in the coming years,” said Steven ...
Ranking Utah’s best sports logos and uniforms — from college classics to bold new looks From Jazz notes to Mammoth tusks, Tribune columnist Gordon Monson weighs in on the state’s top looks.
Company News Published 06/18/2025, 07:35 AM 0 Biogen initiates phase 3 trial of omaveloxolone for children with FA BIIB -0.66% ...
As part of his first time attending Cannes, Biogen’s Raval said he’s thrilled to be able to bring the rare disease community to the festival, especially after the work was awarded earlier in the week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results